PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 348.00
Bid: 346.50
Ask: 348.50
Change: 0.50 (0.14%)
Spread: 2.00 (0.577%)
Open: 340.00
High: 350.00
Low: 340.00
Prev. Close: 347.50
VLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Apr 2012 07:00

RNS Number : 1608B
Volex PLC
12 April 2012
 



For immediate release 12 April 2012

VOLEX plc

Trading Update

Volex plc ('Volex' or the 'Group'), the global provider of electrical, digital and optical connections, today releases the following trading update for the three months ended 1 April 2012.

Trading in the final quarter of FY2012 remained resilient despite continuing economic uncertainty. Consumer revenue for the final quarter was in line with the same period last year, while year-on-year revenue growth in the Healthcare sector was again in excess of 20%. Telecoms/Datacoms revenue in the quarter continued to be affected by reduced spend by telecoms operators while trading in the Industrial sector, as predicted, largely recovered from the customer destocking experienced in Q3 FY2012. Consequently overall Q4 FY2012 Group revenue was down slightly on the same period last year, but still up almost 6% for the year as a whole.

The exceptional start-up costs reported in the Interim Management Statement of 13 January 2012 have, as anticipated, been winding down during the course of Q4 due to the on-going operational efficiency and quality improvements. As a result we have exited the year at the targeted yields and the costs for the full year FY2012 are at the lower end of the $5m-$6m range communicated in the IMS. Excluding the impact of these start-up costs, normalised(i) gross margin in Q4 FY2012 was modestly above management's stated objective of exiting the year at around 20%. As a result, full year normalised(i) operating profit will be slightly ahead of market expectations for the twelve months to 1 April 2012.

Despite significantly increased investment in capital expenditures and other areas of the business, cash generation continues to be strong with a net cash position again reported at the year end, ahead of market expectations.

Whilst economic conditions are expected to continue to be challenging in FY2013, the Board is confident that on-going investments, particularly in the areas of sales, operations and technology, will enable the business to deliver continued growth in revenues, margins and profit in line with management's expectations.

Results for the year ended 1 April 2012 will be announced on Tuesday 29 May 2012.

 

(i) Normalised results stated before exceptional start-up costs and share based payments charge

 

- END -

 

 

 

Volex plc

Ray Walsh Group Chief Executive +44 20 3370 8830

Andrew Cherry Group Finance Director +44 20 3370 8830

Buchanan

Charles Ryland / Helen Chan / Louise Hadcocks +44 20 7466 5000

Forward looking statements

Certain statements in this announcement are forward-looking statements which are based on Volex's expectations, intentions and projections regarding its future operating performance and objectives, anticipated events or trends and other matters that are not historical facts. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words as 'anticipates', 'aims', 'could', 'may', 'should', 'expects', 'believes', 'intends', 'plans', 'targets', 'goal' or 'estimates'. By their very nature forward-looking statements are inherently unpredictable, speculative and involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, by way of example only and not limited to, general economic conditions, currency fluctuations, competitive factors, the loss or failure of one or more major customers, changes in raw materials or labour costs, and issues associated with implementing our strategic plan among other risks. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law, Volex undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFUFIFFESEDL
Date   Source Headline
19th Oct 20205:47 pmRNSHolding(s) in Company
15th Oct 20207:00 amRNSTrading Update
26th Aug 20205:02 pmRNSHolding(s) in Company
26th Aug 20208:57 amRNSDirector/PDMR Shareholding
19th Aug 20207:00 amRNSDirector/PDMR Shareholding
7th Aug 20205:06 pmRNSPDMR / PCA Dealing
5th Aug 202010:28 amRNSPDMR / PCA Dealing
30th Jul 20204:29 pmRNSCompany Secretary Change
30th Jul 20204:26 pmRNSResult of AGM
30th Jul 20207:00 amRNSAGM Statement
6th Jul 20203:41 pmRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSNotice of AGM and Annual Report and Accounts
26th Jun 20203:50 pmRNSHolding(s) in Company
26th Jun 20207:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
23rd Jun 20207:00 amRNSDirector/PDMR Shareholding
22nd Jun 20206:23 pmRNSDirector/PDMR Shareholding
18th Jun 20207:01 amRNSInvestor Presentation
18th Jun 20207:00 amRNSPreliminary Group Results FY2020
1st Jun 20204:41 pmRNSSecond Price Monitoring Extn
1st Jun 20204:36 pmRNSPrice Monitoring Extension
29th Apr 20204:19 pmRNSDirector/PDMR Shareholding
24th Apr 20204:36 pmRNSPrice Monitoring Extension
20th Apr 20204:35 pmRNSPrice Monitoring Extension
16th Apr 20207:00 amRNSTrading Update
6th Apr 20204:35 pmRNSPrice Monitoring Extension
6th Apr 20201:31 pmRNSDirector/PDMR Shareholding
3rd Apr 20203:41 pmRNSDirector/PDMR Shareholding
1st Apr 20202:54 pmRNSDirector/PDMR Shareholding
30th Mar 20201:42 pmRNSDirector/PDMR Shareholding
25th Mar 20204:42 pmRNSSecond Price Monitoring Extn
25th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSChange of Registered Office
23rd Mar 20204:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20205:00 pmRNSDirector/PDMR Shareholding
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
11th Mar 20202:03 pmRNSHolding(s) in Company
9th Mar 20204:30 pmRNSDirector/PDMR Shareholding
6th Mar 20204:41 pmRNSSecond Price Monitoring Extn
6th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Mar 202012:07 pmRNSSecond Price Monitoring Extn
6th Mar 202012:02 pmRNSPrice Monitoring Extension
2nd Mar 202012:47 pmRNSDeferred Consideration for Servatron Acquisition
26th Feb 20203:49 pmRNSEBT Share Purchase
17th Feb 20207:00 amRNSStatement Regarding Situation in China - Update
13th Feb 20205:26 pmRNSEBT Share Purchase
10th Feb 20209:57 amRNSStatement Regarding Current Situation in China
15th Jan 20203:47 pmRNSHolding(s) in Company
15th Jan 20203:34 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.